Rabies: Epidemiology, pre- and postexposure immunization;Tollwut: Epidemiologie, prä- und postexpositionelle immunisierung

Wiener Klinische Wochenschrift

Volumn 118, Issue 11-12, 2006, Pages 312-320

  Kollaritsch, Herwig ^a   Maurer, Wolfgang ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIV KLIN KINDER JUGENDHEILKUNDE   (Austria)

Author keywords

Epidemiology; Postexposure prophylaxis; Rabies; Vaccination

Indexed keywords

AUSTRIA; ENDEMIC DISEASE; GENERAL PRACTITIONER; HUMAN; IMMUNIZATION; RABIES; REVIEW; TRAVEL;

EID: 33746333868     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-006-0606-1     Document Type: Review

References (28)

1. Krause R, Bago Z, Revilla-Fernandez S, Loitsch A, Allerberger F, Kaufmann P, Smolle KH, Brunner G, Krejs GJ (2005) Travel associated rabies in an Austrian man. Emerg Inf Dis 11: 719-721
2. Gerstl F, Maurer W (1991) Die Indikation zur postexpositionellen Tollwutprophylaxe. Öst Ärztezeitung 46: 26-36
3. Maurer W, Beck G (1999) Die Indikation zur postexpositionellen Tollwutprophylaxe (PEP) - geänderte Seuchenlage in Österreich. Ost Ärztezeitung 22: 40-45
4. Warrell MJ, Warrell DA (2004) Rabies and other lyssavirus diseases. Lancet 363: 959-969
5. Bisseru B (1972) Rabies. William Heinemann Medical Books, London
6. Maurer W, Guber SE (2001) Rabies vaccination of foxes: vaccine residues as a potential biohazardous waste. The Pediatric Infectious Disease Journal 20: 1184-1185
7. Gibbons RV (2002) Cryptogenic rabies, bats and the question of aerosol transmission. Ann Emerg Med 39: 528-536
8. Bleck TP, Rupprecht CE (2005) Rhabdoviruses. In: Mandell GL, Bennett JE, Dolin R (eds) Principles and practice of infectious diseases. Churchill Livingstone 2005: 2047-2056
9. Willoughby RE Jr, Tieves KS, Hoffman GM, Ghanayem NS, Amlie-Lefond CM, Schwabe MJ, Chusid MJ, Rupprecht CE (2005) Survival after treatment of rabies with induction of coma. N Engl J Med 352 (24): 2508-2514
10. Burton EC, Burns DK, Opatowsky MJ, El-Feky WH, Fischbach B, Melton L, Sanchez E, Randall H, Watkins DL, Chang J, Klintmalm G (2005) Rabies encephalomyelitis: clinical, neuroradiological, and pathological findings in 4 transplant recipients. Arch Neurol 62 (6): 873-882
11. Robert Koch Institut (2005) Zu Tollwuterkrankungen nach Organtransplantationen. Epidemiologisches Bulletin 7/2005
12. World Health Organization (2005) WHO expert consultation on Rabies. First Report. Technical Report Series 931
13. Wiedermann G (2000) Tollwut. In: Kollaritsch H, Wiedermann G (Hrsg) Leitfaden für Schutzimpfungen. Springer, Wien New York, S 248
14. Plotkin SA, Rupprecht CE, Koprowski H (2004) Rabies vaccine. In: Plotkin SA, Orenstein WA (eds) Vaccines, 3rd edn. Saunders, Philadelphia, pp 1011-1038
15. WHO (1996) WHO Recommendation on rabies post-exposure treatment and the correct technique of intradermal immunization against rabies. http://whqlibdoc.who.int/hq/1996/WHO_EMC_ZOO_96.6.pdf
16. Dreesen DW, Bernard KW, Parker RA (1986) Immune-complex like disease in 23 persons following a booster dose of rabies human diploid cell vaccine. Vaccine 4: 45-49
17. CDC: Human Rabies Prevention - United States (1999) Recommendations of the Advisory Committee on Immunization Practices (ACIP). www.cdc.gov/mmwr/PDF/ RR/RR4801.pdf
18. Schweizerisches Bundesgesundheitsamt (2004) Prä- und postexpositionelle Tollwutprophylaxe beim Menschen: Empfehlungen des Bundesamtes für Gesundheit, der Arbeitsgruppe Tollwut und der Schweizerischen Kommission für Impffragen: www.bag.admin.ch/infekt/publ/supplementa/d/ supp10_tollwut.pdf
19. Bundesministerium für Gesundheit und Frauen (2005) Der österreichische Impfplan: www.bmgf.gv.at
20. Thraenhart O, Kreuzfelder E, Hillebrandt M (1994) Long term humoral and cellular immunity after vaccination with cell culture rabies vaccines in man. Clin Immunol Immunopathol 71: 287-292
21. Strady A, Lang J, Lienard M, Blondeau C, Jaussaud R, Plotkin SA (1998) Antibody persistence following pre-exposure regimens of cell-culture rabies vaccines: 10-year follow-up and proposal for a new booster policy. J Infect Dis 177 (5): 1290-1295
22. Dreesen DW, Briggs DJ (2002) 14-year duration of neutralizing antibody following booster with rabies PCECV and anamnestic response to a single booster dose. Abstract No. 71, XIII International meeting on research advances and rabies control in the Americas
23. STIKO (2004) Mitteilungen der ständigen Impfkommission (STIKO) am Robert Koch Institut. Epid Bull 30: 235-250
24. Austria Codex Fachinformation (2005) Rabipur. Österr Apothekerverlagsgesellschaft
25. Nicholson KG (1990) Modern vaccines: rabies. Lancet 335: 1201-1205
26. Thraenhart O, Marcus I, Kreuzfelder E (1994) Current and future immunoprophylaxis against rabies: reduction of treatment failures and errors. Curr Top Microbiol Immunol 187: 173-194
27. Rendi-Wagner P, Hoeller K, Kollaritsch H; Österreichische Expertengruppe für Reisemedizin (2004) Immunization recommendations for travel in the Mediterranean area. Wien Klin Wochenschr 116: 652-660
28. Rendi-Wagner P, Jeschko E, Kollaritsch H; Österreichische Expertengruppe für Reisemedizin (2005) Travel vaccination recommendations for Central and Eastern European countries based on country-specific risk profiles. Wien Klin Wochenschr 117 [Suppl 4]: 11-19